GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Goodbody Health Ltd (OTCPK:GDBYF) » Definitions » Net-Net Working Capital

Goodbody Health (Goodbody Health) Net-Net Working Capital : $0.05 (As of Sep. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Goodbody Health Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Goodbody Health's Net-Net Working Capital for the quarter that ended in Sep. 2022 was $0.05.

The industry rank for Goodbody Health's Net-Net Working Capital or its related term are showing as below:

GDBYF's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.72
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Goodbody Health Net-Net Working Capital Historical Data

The historical data trend for Goodbody Health's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goodbody Health Net-Net Working Capital Chart

Goodbody Health Annual Data
Trend Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Dec21
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 0.02 1.08 0.31 0.10

Goodbody Health Quarterly Data
Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.10 0.10 0.07 0.05

Competitive Comparison of Goodbody Health's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Goodbody Health's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goodbody Health's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Goodbody Health's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Goodbody Health's Price-to-Net-Net-Working-Capital falls into.



Goodbody Health Net-Net Working Capital Calculation

Goodbody Health's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2021 is calculated as

Net-Net Working Capital(A: Dec. 2021 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(8.069+0.75 * 0.37+0.5 * 0.783-5.02
-0-0)/36.4962
=0.10

Goodbody Health's Net-Net Working Capital (NNWC) per share for the quarter that ended in Sep. 2022 is calculated as

Net-Net Working Capital(Q: Sep. 2022 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(3.454+0.75 * 0.086+0.5 * 0.548-1.999
-0-0)/36.4963
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Goodbody Health  (OTCPK:GDBYF) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Goodbody Health Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Goodbody Health's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Goodbody Health (Goodbody Health) Business Description

Traded in Other Exchanges
N/A
Address
Stubbs Lane, Beckington Frome, The Blue Building, Somerset, GBR, BA11 6TE
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.